Nanobiotechnology‐Based Approaches for Uveal Melanoma Treatment
Nadezhda A. Pechnikova(Aristotle University of Thessaloniki), Alexey V. Yaremenko(Brigham and Women's Hospital), Malamati Poimenidou(Aristotle University of Thessaloniki), Ivan V. Zelepukin(Uppsala University), Chrysi Patsidou(Aristotle University of Thessaloniki), Ioannis Iliadis(Aristotle University of Thessaloniki), Diamantis Almaliotis(Aristotle University of Thessaloniki), Maria Zafeiriou‐Chatziefraimidou(Aristotle University of Thessaloniki), Ioannis Tsinopoulos(Aristotle University of Thessaloniki)
Cited by 0
Related Papers
Cancer nanomedicine toward clinical translation: Obstacles, opportunities, and future prospects
|Med|2022|222
Nanoparticle-based drug delivery <i>via</i> RBC-hitchhiking for the inhibition of lung metastases growth
|Nanoscale|2018|180
Rediscovery of mononuclear phagocyte system blockade for nanoparticle drug delivery
|Nature Communications|2024|162
Enhancement of the blood-circulation time and performance of nanomedicines via the forced clearance of erythrocytes
|Nature Biomedical Engineering|2020|146
Oral drug delivery platforms for biomedical applications
|Materials Today|2023|123